News
VYNT
0.9600
+4.22%
0.0389
18 Stocks Moving in Monday's Pre-Market Session
Gainers DiDi Global Inc. (NYSE: DIDI) rose 52.4% to $2.82 in pre-market trading following Wall Street Journal report indicating China authorities will lift ban on new users for those companies.
Benzinga · 06/06 10:33
Vyant Bio Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services
CHERRY HILL, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’s c...
GlobeNewswire · 06/01 22:05
44 Stocks Moving In Wednesday's Mid-Day Session
Gainers
Benzinga · 06/01 16:14
18 Stocks Moving in Wednesday's Pre-Market Session
Gainers Endo International plc (NASDAQ: ENDP) rose 46.1% to $0.7710 in pre-market trading after gaining over 12% on Tuesday.
Benzinga · 06/01 10:17
Stocks That Hit 52-Week Lows On Monday
  On Monday, 149 companies reached new 52-week lows.
Benzinga · 05/23 16:12
Vyant Bio to Present at the H.C. Wainwright Global Investment Hybrid Conference
Cherry Hill, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT), is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’s c...
GlobeNewswire · 05/19 12:30
--HC Wainwright Trims Vyant Bio's Price Target to $3 From $4, Buy Rating Kept
MT Newswires · 05/17 11:34
Vyant Bio GAAP EPS of -$0.32 misses by $0.16, revenue of $0.31M beats by $0.01M
Vyant Bio press release (NASDAQ:VYNT): Q1 GAAP EPS of -$0.32 misses by $0.16. Revenue of $0.31M (+47.6% Y/Y) beats by $0.01M.
Seekingalpha · 05/16 14:32
Vyant Bio GAAP EPS of -$0.32 misses by $0.16, revenue of $0.3M in-line
Vyant Bio press release (NASDAQ:VYNT): Q1 GAAP EPS of -$0.32 misses by $0.16. Revenue of $0.3M (+200.0% Y/Y) in-line. Shares +1.72% PM.
Seekingalpha · 05/16 13:04
BRIEF-Vyant Bio Reports First Quarter 2022 Results And Provides Strategic And Business Highlights
reuters.com · 05/16 12:38
-- Earnings Flash (VYNT) VYANT BIO Posts Q1 Revenue $303,000
MT Newswires · 05/16 08:33
Notable earnings after Monday's close
ADMP, ALBO, ANY, AREC, ASTS, AXDX, CCSI, OTCQX:CWBHF, CWBR, CYRN, DAC, DADA, DNA, EGLX, FTK, FUV, GAN, GLBE, GNLN, HYRE, INPX, IONQ, IPWR, ISUN, IZEA, KBNT, KULR, MARK, MVST, OTCQB:NEXCF,
Seekingalpha · 05/15 21:35
Vyant Bio Announces Investor Conference Call and Webcast for the First Quarter 2022
CHERRY HILL, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’s cent...
GlobeNewswire · 05/10 20:01
Vyant Bio Announces Participation in BioNJ’s 12th Annual BioPartnering Conference
CHERRY HILL, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders, announced that Jay R...
GlobeNewswire · 05/05 20:30
BRIEF-Vyant Bio Inc Files For Offering Of Up To 5.8 Million Shares Of Common Stock By The Selling Stockholder - SEC Filing
reuters.com · 04/29 21:48
BRIEF-Vyant Bio Inc May Issue And Sell Shares Of Up To $20 Mln
reuters.com · 04/11 10:45
VTNR, MF and SABS among mid-day movers
Gainers: Longeveron (LGVN) +62%. Clovis Oncology (CLVS) +61%. Icosavax (ICVX) +26%. Integrated Media Technology (IMTE) +28%. SAB Biotherapeutics (SABS) +21%. Local Bounti (LOCL) +21%. CPS Technologies (CPSH) +18%. Vector Group
Seekingalpha · 03/31 16:49
Clovis, Longeveron top healthcare gainers; while Clarus, Acutus among losers
Gainers: Clovis Oncology (CLVS) +68%. Longeveron (LGVN) +36%. Icosavax (ICVX) +27%. Creative Medical Technology (CELZ) +25%. Nano-X Imaging (NNOX) +22%. Losers: Clarus Therapeutics (CRXT) -27%. Acutus Medical (AFIB) -18%. Vyant Bio (VYNT) -15%. Phreesia (P...
Seekingalpha · 03/31 14:07
23 Stocks Moving in Thursday's Pre-Market Session
Gainers IZEA Worldwide, Inc. (NASDAQ: IZEA) rose 33.3% to $1.92 in pre-market trading after the company reported Q4 EPS results up from last year and better-than-expected sales results.
Benzinga · 03/31 10:15
Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?
Investor Place · 03/30 17:41
More
Webull provides a variety of real-time VYNT stock news. You can receive the latest news about Vyant Bio Inc through multiple platforms. This information may help you make smarter investment decisions.
About VYNT
Vyant Bio, Inc., formerly Cancer Genetics, Inc., is a biotechnology drug discovery company. The Company is engaged in identifying molecule therapeutics and decision making through in silico, in vitro, and in vivo modalities. It offers AnalytiX platform, which analyzes functional data to identify the drug candidates, targets, and biomarkers via a rank order approach. Its microOrgan technology uses functional microtissues engineered from induced pluripotent stem cells (iPSC) to facilitate human-based drug discovery. It operates two subsidiaries, vivoPharm, Pty Ltd. (vivoPharm) and StemoniX, Inc. (StemoniX). Its subsidiary, vivoPharm, offers preclinical test systems supporting clinical diagnostic offerings at early stages valued by the pharmaceutical industry, biotechnology companies, and academic research centers. The StemoniX develops and manufactures human induced pluripotent stem (iPS) cell-derived neural and cardiac screening platforms for drug discovery and development.